TrialCell metabolism2019
SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus.
David A Hess et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this papertrialcites it